Protagonist Therapeutics

Protagonist Therapeutics: Proprietary peptide technology platform to develop oral targeted therapy-based drugs and injectables for rare diseases. PTG-300 injectable hepcidin mimetic Ph 2 trials ongoing in polycythemia vera and hereditary hemochromatosis; positive updated Ph 2 results in PV presented at ASH 2020. PN-943 oral GI-restricted alpha-4-beta-7 antagonist Ph 2 in ulcerative colitis study sites activated; PTG-200, partnered w/ Janssen, oral GI-restricted IL-23R antagonist Ph 2 Crohn’s disease study ongoing.
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Anti-inflammatory, Autoimmune, Gastrointestinal, Rare Disease
Public, USA
Market Cap
1B +
Therapeutic Modalities
Platform Technology
521 Cottonwood Drive
Suite 100
Milpitas, CA 95035
United States

Company Participants at Protagonist Therapeutics PTG-300 Opportunity Update Webinar

  • Dinesh V Patel, PhD, President & CEO

Top 10 Holders of Protagonist Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 23.38 6,413,749 166.69 13F 12/31/20
BVF, Inc. 15.58 4,273,588 111.07 13F 12/31/20
BVF Partners LP 15.58 4,273,588 111.07 Stakes 12/31/20
RTW Investments LP 13.30 3,650,069 94.87 Stakes 12/31/20
Consonance Capital Management LP 9.95 2,729,709 70.95 13F 12/31/20
Johnson & Johnson Innovation JJDC, Inc. 8.93 2,449,183 63.65 13F 12/31/20
Farallon Capital Management LLC 8.84 2,425,000 63.03 Stakes 12/31/20
The Vanguard Group, Inc. 7.29 1,999,984 51.98 Funds 2/28/21
Vanguard Group, Inc. (Subfiler) 6.97 1,912,272 49.70 13F 12/31/20
BlackRock Fund Advisors 5.46 1,496,659 38.90 13F 12/31/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.